Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
10 evidence topics · 10 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionProduct descriptionProduct information
10 evidence topics · 10 sources